drugset / Trial / NCT03633890
DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris
Phase 4
Unknown
102 enrolled
Beijing Anzhen Hospital
Jiangsu Kangyuan Pharmaceutical Co. Ltd · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to evaluate the efficacy and safety of traditional Chinese medicine DaZhu Rhodiola Rosea Capsule for treatment of coronary artery disease by observing angina symptoms, exercise capacity, and quality of life.
Timeline
- Start
- 2018-08
- Primary completion
- 2019-02
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DaZhu Rhodiola Rosea Capsule | Traditional medicine (herbal / TCM) | 4 unknown | Oral |